Literature DB >> 2885377

Development and preliminary evaluation of a slide latex agglutination assay for detection of Clostridium perfringens type A enterotoxin.

B A McClane, J T Snyder.   

Abstract

A slide latex agglutination (SLA) assay was developed for rapid screening for Clostridium perfringens type A enterotoxin (CPE). SLA specifically detected CPE added to buffer or normal feces (sensitivity limit of 1 microgram CPE/g feces). Using clinical fecal samples from C. perfringens food poisoning cases, a strong correlation was shown between SLA results and results from other CPE assays and between SLA results and illness status.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2885377     DOI： 10.1016/0022-1759(87)90181-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN： 0022-1759            Impact factor:   2.303


  4 in total

Review 1.  Clostridial enteric diseases of domestic animals.

Authors:  J G Songer
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

2.  Detection of enterotoxigenic Clostridium perfringens in food and fecal samples with a duplex PCR and the slide latex agglutination test.

Authors:  P Fach; M R Popoff
Journal:  Appl Environ Microbiol       Date:  1997-11       Impact factor: 4.792

3.  Characterization of an outbreak of Clostridium perfringens food poisoning by quantitative fecal culture and fecal enterotoxin measurement.

Authors:  G Birkhead; R L Vogt; E M Heun; J T Snyder; B A McClane
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

4.  Innovative and Highly Sensitive Detection of Clostridium perfringens Enterotoxin Based on Receptor Interaction and Monoclonal Antibodies.

Authors:  Thea Neumann; Maren Krüger; Jasmin Weisemann; Stefan Mahrhold; Daniel Stern; Martin B Dorner; Cécile Feraudet-Tarisse; Christopher Pöhlmann; Katharina Schulz; Ute Messelhäußer; Dagmar Rimek; Frank Gessler; Thomas Elßner; Stéphanie Simon; Andreas Rummel; Brigitte G Dorner
Journal:  Toxins (Basel)       Date:  2021-04-08       Impact factor: 4.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.